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บทคดัยอ่ 
วตัถปุระสงค:์ ยาเป็นทรพัยากรส าคญัในโรงพยาบาล จงึตอ้งมกีารบรหิารจดัการ
ใหม้เีพยีงพอต่อการรกัษาผูป้่วย งานวจิยันี้มวีตัถุประสงค์เพื่อก าหนดนโยบายที่
เหมาะสมในการจดัการสินค้าคงคลงัยาที่มมีูลค่าปานกลางและมูลค่าน้อย วิธี
การศึกษา: การวเิคราะหโ์ดยอาศยัขอ้มลูการใช้ยาจรงิในอดตีของโรงพยาบาลรฐั
กรณีศึกษา และเปรยีบเทยีบนโยบาย Min/Max ที่โรงพยาบาลใช้ในปจัจุบนักบั
นโยบายที่ได้จากการทบทวนวรรณกรรม จากงานวิจยัที่ผ่านมาได้มกีารศึกษา
นโยบายการจดัการสนิคา้คงคลงัทีเ่หมาะสมของกลุม่ยาในโรงพยาบาลทีม่มีลูค่าสูง 
(ยากลุม่ A) ไปแลว้ การศกึษานี้มุ่งที ่กลุ่มยาทีม่มีูลค่าปานกลาง (ยากลุ่ม B) และ
กลุ่มยาทีม่มีูลค่าน้อย (ยากลุ่ม C) ผลการศึกษา: ส าหรบัยาทีม่มีูลค่าปานกลาง
และมูลคา้น้อย นโยบาย Min/Max ไม่เหมาะสมเมื่อเทยีบกบันโยบายอื่นทีพ่บใน
วรรณกรรม โดยนโยบาย Min/Max ซึง่พจิารณาเพยีงปจัจยัดา้นปรมิาณความ
ตอ้งการเพยีงปจัจยัเดยีวโดยไม่สนใจความส าคญัดา้นการรกัษาจะไม่เหมาะสม
เนื่องจากอาจท าใหเ้กดิการขาดแคลนและเกดิการเก็บสนิคา้ขึ้นได้  สรปุ: พบว่า
การก าหนดนโยบายการจดัการสนิคา้คงคลงัในโรงพยาบาลนัน้ ควรจะตอ้งค านึง
ปจัจยัทางดา้นความตอ้งการและความส าคญัในการรกัษาไปพรอ้มกนั  
ค าส าคญั: การจดัการสนิคา้คงคลงั, โรงพยาบาล, ยา  
 
Abstract 
Objective: Drugs are the important resource of the hospital. The hospital 
keeps stock and manages drug inventory in order to ensure adequate on-
hand inventory for patients. This study aimed to determine inventory policy 
suitable for drugs with medium and low consumption value. Methods: This 
study used historical drug demand data of a large government hospital to 
test the existing Min/Max inventory policy against other policies found in the 
literature. Since policy suitable for drugs with high consumption value 
(group A) was known, we focused on drugs with medium (group B) and low 
(group C) consumption value. Results: For groups B and C, the Min/Max 
inventory policy was not suitable compared with the others from the 
literature. This was because it took only the consumption value, not the 
drugs’ clinical importance, into account. The sole Min/Max policy could 
potentially cause shortage and overstock. Conclusion: To apply a proper 
inventory management policy for drugs in the hospital, clinical factors, in 
addition to consumption value, should be taken into consideration.  
Keywords: inventory management, hospital, drugs  
Introduction 
In Thailand, drug expenditure has been increasing from 
36,506 million Baht in 2000 to 98,375 million Baht in 2008. 
With an average increase rate of 15% per year, the drug 
expenditure continues to rise. It has been estimated that 
46.7% of the healthcare expenditure is the drug costs which 
is as twice as that if the developed countries.1 It is obvious 
that almost half of the healthcare expenditure in Thailand is 
the cost of drugs.  
To have an uninterrupted healthcare service, hospitals 
usually have the safety stock, or the minimum inventory 
level. To accurately estimate such safety stock, the monthly 
amount of drugs use from each of the hospital’s departments 
is accumulated. This monthly drug usage volume is called 
the Monthly Sale or Msale. It has been accepted that once 
the drug inventory on hand is lower than 70 – 80% of the 
Msale, the pharmacist responsible for the central drug 
distribution center should be prompted to place the order. 
The purchase volume should increase the inventory level to 
100 – 150% of Msale. This type of practice is known as the 
Min/Max policy which has been widely applied to all drugs 
items in the hospital. However, since most drug items have 
different demand characters, such universal use of Min/Max 
policy could be problematic.   
Our previous study investigated drug inventory policies 
suitable for different types of drug regarding the usage 
volume. Drugs with a usage volume of 70% of the total 
annual drug expenditure (group A) were selected for 
analysis. The history data of drug usage in the fiscal year 
2012 were tested against the Min/Max policy and other 
policies. It was found that the single Min/Max inventory 
management policy was not appropriate for all drug items 
especially those classified as vital drugs, which in part are 
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those for unusual urgent medical needs such as anti-venom 
serums. With the unpredictable demand of these vital drugs, 
a universal Min/Max policy could easily lead to an inventory 
shortage. This kind of problem is devastating since these 
vital drugs need to be readily available at all times as the 
life-saving items.2   
To further our investigation on the issue, we conducted 
this present study to determine the appropriate policy 
beyond group A drugs, including those with medium and low 
usage volume, i.e., groups B and C, respectively. In this 
study we defined groups B and C drugs as those with 15% 
and 5% of the total annual usage value. As a retrospective 
study, we used a set of historical data from the out-patient 
department (OPD) of a government hospital in the fiscal 
years of 2008 – 2010 to compare the present Min/Max 
inventory policy with other policies guided by the literature.  
  
Methods 
 
Recent inventory management policies of the hospital 
and general industrial goods were reviewed from the 
literature. System analysis in this present study was the 
modified method from our previous investigation on the drug 
inventory management system.2 Historical demand data of 
the drug usage in the fiscal years of 2008 – 2010 were 
retrieved from the study hospital information system and 
categorized the total annual consumption value of each drug 
according to the ABC analysis.3 Only those drugs with the 
15% and 5% of the total annual drug  consumption values, 
or groups B and C, respectively, were selected for the 
analysis.  
Of these select groups B and C drugs, based on the 
additional information provided by the hospital, we further 
classified clinical importance of the items according to the 
VEN classification.4,5 Once the ABC and VEN classification 
systems were applied simultaneously, six groups of drugs 
were classified, specifically drugs with medium usage and 
vital clinical importance (BV), drugs with medium usage and 
essential clinical importance (BE), drugs with medium usage 
and non-essential clinical importance (BN), drugs with low 
usage and vital clinical importance (CV), drugs with low 
usage and essential clinical importance (CE), drugs with low 
usage and non-essential clinical importance (CN).  
After the ABC/VEN classification, we used statistical 
analysis to classify drug items based on the demand 
characters which consisted of the distribution and the 
presence of the demand, in other words, the trend demand.3 
These statistical methods included, but not limited to Run 
Test, Kolmogorov–Smirnov Test and Peterson–Silver Rule. 
We then test each inventory management policy using the 
Min/Max policy as the base case since it has been widely 
used in the hospitals in Thailand. Once all policies were 
compared, policies with the highest indices were determined.  
 
1) Literature review  
Inventory management aims at minimizing the inventory 
cost, and at the same time maintaining the desirable service 
level to the customers. However, since the inventory of the 
hospitals contains medications in various forms as well as 
non-pharmaceutical medical products. These various 
products also have various costs. To better manage the 
inventory, one must prioritize the products by their costs. 
Otherwise, to micromanage every item of the products could 
be too costly and time-consuming.  
 
1.1) The prioritization of the drug inventory based on 
inventory cost and clinical importance  
To prioritize drug items in the hospital inventory based 
on their cost and clinical importance, the ABC Analysis and 
the VEN Classification have been recommended. The ABC 
Analysis, or the 20 - 80 Rules or Pareto Analysis3, has been 
widely used in classifying the inventory with vairous kinds of 
products. Based on ABC Analysis, products are classified 
into three groups. First, group A is the products accounting 
for 70% of the total inventory value and only 20% of the 
number of the inventory items. Group B products are those 
accounting for 15% of the total inventory value and about 
30% of the inventory item numbers. Last, products in group 
C account for 5% of the total inventory value and as high as 
50% of the inventory item numbers. For the medical 
products in Thailand, service levels have been reported to 
be 98:95:90 for groups A, B and C, respectively.4  
In addition to the monetary value and item quantity, 
medical products possess the attribute of clinical 
importance that needs to prioritize in their inventory 
management. The VEN classification reflects the medical 
necessity and urgency aspect of each of the products.5 
Based on the VEN classification, three classes include class 
V (Vital), class E (Essential), and class N (non-essential). 
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Class V refers to those drugs for life-saving or highly 
emergent medical conditions. They need to be readily 
available at all time. Drugs in class E are needed in general 
medical conditions; while those in class N are those for the 
least critical conditions and that can be substituted by other 
drugs. In each hospital, individual drug items in each of the 
there VEN classes can be revised annually.  
To better manage the inventory of the hospital, the 
simultaneous application of the ABC and VEN classifications 
has been widely recommended. The method takes the 
annual consumption value and the clinical importance of the 
drug products into account simultaneously, by the ABC and 
VEN systems, respectively.  
 
1.2) ABC/VEN classification system   
Based on this ABC/VEN system, nine groups are 
classified. These include those with high consumption value 
and high clinical importance (1-AV), high consumption value 
and moderate clinical importance (2-AE), high consumption 
value and low clinical importance (3-AN), medium 
consumption value and high clinical importance (4-BV), 
medium consumption value and clinical importance (5-BE), 
medium consumption value and low clinical importance (6-
BN), low consumption value and high clinical importance (7-
CV), low consumption value and moderate clinical 
importance (8-CE), low consumption value and clinical 
importance (9-CN). In our present study, we studied only 
those with medium and low consumption values, i.e., groups 
4 to 9.   
 
1.3) Inventory management policy   
In terms of stock replenishing, the inventory 
management policy helps identify when to place and order, 
and how much to order to minimize the total inventory cost 
per time per unit. Two kinds of policy have been used.3,6 In 
the first system, the (s, Q) inventory policy or the two-bin 
system, one would place an order when the inventory 
reaches the re-order point (s), with an order quantity (Q). 
This approach is an application of the economic order 
quantity (EOQ). This (s, Q) system has been widely used 
and is effective in controlling the inventory quantity and 
minimizing the inventory cost.  
Like the (s, Q) inventory policy, the (s, S) inventory 
policy indicates that one should place an order when the 
inventory reaches the re-order point (s). However, the (s, S) 
inventory policy suggests that the order quantity should be 
the one make the inventory reach the maximum inventory 
level (S). It has been found this (s, S) inventory policy has 
been widely with all drug items in all hospitals’ inventory 
system.  
It is thus concluded that the inventory policy, both (s, Q) 
and (s, S), suggests a continuous monitoring of the inventory 
level. Once the inventory level drops and reaches a the re-
order point (s), the order must be place in a timely fashion, 
either with an economic order quantity by the (s, Q) policy, 
or an the quantity that helps reach the maximum inventory 
level by the (s, S) policy.  
In addition to those factors described above, the use of 
(s, Q) or (s, S) policy depends also on other inventory 
characteristics. For example, whether the product demand is 
static or variable could determine the policy. Many inventory 
management policies have been developed to be specific for 
various demand characters as follows.  
First the policy that uses mean and standard deviation of 
the inventory consumption is specific to drugs with static and 
random demand, in other words, no trend of the demand.2,7-
11 The policy that uses probability to determine re-order point 
(ROP) and order quantity is more specific to drugs with 
lumpy and random demand (i.e., no trend), and drugs that 
their consumption values have non-normal distribution.7,8 The 
policy that uses probability and regression analysis to 
determine ROP and order quantity is specific to drugs with 
lumpy and trend demand.7,8   
With various inventory policies mentioned above, four 
inventory management policies specific to various drugs’ 
consumption could be found. First, it is the policy drugs with 
normal distribution of the demands where their demands are 
uniformly distributed and no trend of the demand is found. 
Second, it is the policy for drugs with normal demand 
distribution with no trend but lumpy demand(s) at some 
times. Third, it is the policy for drugs with normal distribution 
and a trend in demand. Last, it is the policy for drugs with 
non-normal distribution of the demand. These policies with 
their corresponding mathematic models for calculating re-
order point and order quantity are shown in Table 1. 
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 Table 1  Inventory policy from previous studies for particular demand characteristics.  
Number Demand character  Inventory policy 
1 
Normal distribution with no trend 
but static demand  
(s,S) policy for normal distribution 
demand3,6 
s = 
n
nLzL weekweek   
S = sk
n
M week 

 
(s,Q) policy for static demand and pack size 
ordering3,6 
s =  1Lday   
Q = 













 
mo,
y
ISn
max
day  
(s,Q) policy based on EOQ3,6 
s = Lday   
Q = 
h
AD2  
2 
Normal distribution with no trend 
but lumpy demand 
(s,Q) policy for normal distribution demand 
with lumpy demand and pack size 
ordering7,8  
s = 
n
nLzL weekweek   
Q = 













 
mo,
y
ISn
max
day  
Fixed Period Demand3 
s = order every month (Fixed ordering time)  
Q = average weekly demand  
Silver Meal3 
The amount to order is determined to achieve the minimum 
inventory cost.  
3 
Normal distribution with trend 
demand 
(s,Q) based on a trend demand7,8 
s =  



dt
ct
dayLzdtdf t  
Q =  



bt
at
kdtdf t  
4 Non-normal distribution  
Fixed Period Demand3 
s = order every month (Fixed ordering time)  
Q = average weekly demand  
Silver Meal3 
The amount to order is determined to achieve the lowest 
inventory cost. 
 
Note: 
s = re-order point (unit)  
L = lead time (day), and it was pre-determined at 14 days12 
week = weekly mean of demands (unit)  
z = the standardized random variable (Z-score) which was determined by the service level based on the VEN groups  
n = service days in a week (day)  
week = standard deviation of the weekly usage (unit)  
S = maximum inventory level (unit)  
M = storage day (day)  
k = special demand that was known before (unit)  
Q = order quantity (pack)  
day  = daily mean of demand (unit)  
I = inventory level at re-order point (unit); I ≤ s  
y = the unit of boxes (unit)  
mo = minimum order quantity, which was pre-determined at zero7 
A  = ordering cost (Baht/order); pre-determined as 5.775 Baht/order12 
D  = weekly demand (unit)  
h = annual inventory unit cost (Baht/unit/year), equal to inventory cost (% per year) x good cost (Baht/unit);  inventory cost was pre-determined at 20.5% per year12 
dt = predicted usage demand at week t; with the presence of trend, t = the week order starting from December 2011 (t = 0, 1, 2, …. )  
 
 
2) Data analysis and the results  
      Input data   
Historical data of drug usage in the fiscal years of 2008 – 
2010 of a university hospital with 1,300 beds were retrieved 
for analysis. Based on the ABC/VEN analysis, drugs were 
classified into nine groups, specifically, AV, AE, AN, BV, BE, 
BN, CV, CE and CN. In this study, we studied only drugs 
with medium and low usage value (groups B and C, 
respectively) which comprised 1,743 drug items. Usage data 
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of these drugs were analyzed to fit the possible four types of 
demand characters from the literature previously described.  
To examine the demand characters of the usage data of 
the study drugs, we used Box Plot test to determine and 
eliminate extreme data values, Kolmogorov-Smirnov test to 
determine normal distribution of the data, Run test to 
examine randomness of the data, regress analysis to 
determine a linear trend of the data, and Peterson-Silver rule 
to examine uniform and lumpy distribution (Figure 1).  
 
 
 
 
 Figure 1  Schematic diagram of the statistical analysis on 
the type of demand characters of the usage data of the study 
drugs.   
 
 
The demand characters of the six study drug groups  
Based on the analysis results, the demand characters 
of the six study drug groups (BV, BE, BN, CV, CE, and 
CN) were as follows. First, drugs with medium consumption 
value and high clinical importance (BV) had three demand 
characters. These characters included 1) normal distribution 
with no trend, and a uniform demand distribution, 2) normal 
distribution with no trend, and a lumpy demand distribution, 
and 3) non-normal distribution. Service level of this group of 
drugs was set at 95%.4  
Second, drugs with medium consumption value and 
clinical importance (BE) also had three demand characters. 
These characters consisted of 1) normal distribution with no 
trend and a uniform demand distribution, 2) normal 
distribution with no trend, and a lumpy demand distribution, 
and 3) non-normal distribution. Service level of this group of 
drugs was set at 94%.  
Third, drugs with medium consumption value and low 
clinical importance (BN) had two demand characters. These 
characters consisted of 1) normal distribution with no trend 
and a uniform demand distribution, and 2) non-normal 
distribution. Service level of this group of drugs was set at 
93%.   
Fourth, drugs with low consumption value and high 
clinical importance (CV) had three demand characters. 
These characters consisted of 1) normal distribution with no 
trend and a uniform demand distribution, 2) normal 
distribution with no trend, and a lumpy demand distribution, 
and 3) non-normal distribution. Service level of this group of 
drugs was set at 90%. 
Fifth, drugs with low consumption value and medium 
clinical importance (CE) had four demand characters. These 
characters consisted of 1) normal distribution with no trend 
and a uniform demand distribution, 2) normal distribution 
with no trend, and a lumpy demand distribution, 3) normal 
distribution with a trend, and 4) non-normal distribution. 
Service level of this group of drugs was set at 89%.  
Sixth, drugs with low consumption value and high clinical 
importance (CN) had three demand characters. These 
characters consisted of 1) normal distribution with no trend 
and a uniform demand distribution, 2) normal distribution 
with no trend, and a lumpy demand distribution, and 3) non-
normal distribution. Service level of this group of drugs was 
set at 88%. From the findings mentioned above, we 
examined the inventory policy suitable for individual demand 
characters  
The historical data of drug usage were tested against the 
existing Min/Max policy and other policies from the literature. 
The results of the potential suitable inventory policies are 
shown in Table 2.  
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 Table 2  Potential suitable inventory policies for each type 
of demand characteristic of drugs with low and medium 
consumption value.  
 
Type of demand character  
1) normal distribution 
with no trend, and a 
uniform distribution 
2) normal distribution 
with no trend and a 
lumpy distribution 
3) normal 
distribution 
with a trend  
4) non-normal 
distribution 
Potential 
policy for 
application  
Min/Max Min/Max Min/Max Min/Max 
(s,S) policy for normal 
distribution of the 
demand 
(s,S) policy for normal 
distribution of the 
demand 
(s,Q) policy for 
the demand 
with a trend 
Fixed Period 
Demand 
(s,Q) policy for a 
uniform distribution of 
the demand and pack 
size ordering  
(s,Q) policy for lumpy 
demand distribution 
and pack size 
ordering  
- Silver Meal 
(s,Q) policy based on 
EOQ 
Fixed Period Demand - - 
- Silver Meal - - 
Drug 
groups 
BV, BE, BN, CV, CN BV, BE, CV, CN CE 
BV, BE, BN, 
CV, CN 
   
3) The measures of the drug inventory performance  
Once the type of the demand characteristics and the 
potential suitable inventory policies for each type of those 
demand characters were determined, the next step was to 
determine which factor or a combination of factors could 
potentially best judge the performance of the inventory 
management policy. This step was also crucial since not 
only the inventory consumption value, but also the clinical 
importance nature of the drug products were of great 
concern. We used a key performance index (KPI) based on 
1) number of shortages, 2) number of days of shortage, 3) 
average inventory level, 4) inventory turnover, and 5) 
inventory-to-sale ratio.7,12  
To properly account for the consumption value and the 
clinical importance of each group of drugs in deciding the 
best indicators, the pairwise ranking technique was used. 
We asked three experts in healthcare logistics to prioritize 
the KPIs for these drugs with medium and low consumption 
values. The results of the KPIs suitable for judging the 
performance of the inventory policy of each of the two 
groups of drugs are shown in Table 3.  
 
 Table 3  Key performance index suitable for judging the 
inventory policy performance of drugs with medium and low 
consumption values by pairwise ranking technique.*  
Drugs with medium consumption 
value (group B)  
Drugs with low consumption 
value (group C) 
BV: number of days of shortage   CV: number of days of shortage  
BE: number of shortages CE: average inventory level 
BN: inventory-to-sale ratio CN: inventory-to-sale ratio 
 * each final decision was made by at least two experts.  
 
 
 Table 4  Inventory policy suitable for each group of drugs and each type of demand characters, and the results of applying 
these suitable KPIs.  
 Policies suitable for each group of drugs and each type of demand characters  
BV: medium 
consumption value and 
high clinical importance  
BE: medium 
consumption value and 
clinical importance 
BN: medium 
consumption value 
and low clinical 
importance  
CV: low consumption 
value and high clinical 
importance  
CE: low consumption value and 
medium clinical importance  
CN: low consumption 
value and low clinical 
importance 
1 2 4 1 2 4 1 4 1 2 4 1 2 3 4 1 2 4 
Su
ita
bl
e p
ol
icy
 
Min/Max                   
(s,S) policy for normal 
distribution of the demand 
                  
(s,Q) policy for uniform 
distribution of the demand 
and pack size ordering 
                  
(s,Q) policy for lumpy 
demand distribution and 
pack size ordering 
                  
(s,Q) policy for the 
demand with a trend  
                  
Fixed Period Demand                    
Silver Meal                    
 The results of applying suitable KPI to each group of drugs and each type of demand characters 
Days of shortage 
(days) 
Number  of  shortage 
(units) 
Inventory-to-
sale ratio 
Days of shortage 
(days) 
Average inventory level Inventory-to-sale ratio 
Ap
pl
ica
tio
n 
es
ul
ts
  
Before application  
 
7 18 15 752 965 192 0.05 0.05 5 11 14 4,570 1,047 6,395 14 0.05 0.05 0.05 
 
After application  
 
# 4 13 # 475 52 0.06 0.14 # 2 # 3,765 42 5,626 6 0.06 0.07 0.09 
  # the results based on the prior inventory policy.   
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Results 
 
After the historical data of drug consumption values were 
tested against the inventory policies including the present 
Min/Max policy as well as those from the literature (Table 2), 
we further tested for each KPI best judging each policy in 
each groups of drugs. The results are shown in Table 4. 
 
 
 
Discussions and Conclusion 
 
Our study tested the suitable inventory management 
policy applied to drugs with various demand characters on 
the actual historical data. We found that most demand 
characters were with non-normal distribution. This suggested 
the usage of the drugs with medium and low consumption 
value (groups B and C) was usually non-uniform and 
unpredictable. Usually drugs with this type of demand 
character should be managed by the Fixed Period Demand 
policy where the Fixed Interval of ordering should be applied. 
Safety stock and re-order point are calculated based on 
average demand or maximum demand. The order quantity 
was varied upon the latest demand.  
For drugs with normal distribution of their usage with no 
trend and a uniform demand, Min/Max policy was found 
suitable. The (s,Q) policy for uniform distribution of the 
demand and pack size ordering was more appropriate if to 
reduce the product shortages. For drugs with normal but 
lumpy distribution of the demand with no trend, (s,Q) policy 
for normal demand distribution and pack size ordering could 
also be applicable. Based on these findings, the Min/Max 
policy did not serve well for a large number of drugs items in 
the hospital. It was mostly suitable for drugs with medium 
consumption value (group B) with normal and uniform 
distribution of the usage. For drugs with a low consumption 
value (group C), Min/Max policy was unsuitable for most of 
them except for those with low consumption value and vital 
clinical importance (group CV).  
In terms of days of shortage, if the recommended policy 
was applied to group BV drugs with the demand character 
type 1 (normal distribution with no trend, and a uniform 
distribution), a similar seven-day of shortage was found 
when compared with the existing Min/Max policy. For group 
BV drugs with a type 2 demand character (normal 
distribution with no trend and a lumpy distribution), the 
shortage decreased from 18 to 4 days. In drugs in BV group 
with a type 4 demand character (non-normal distribution), a 
small decrease of 15 to 13 days in the shortage was found.  
Regarding number of the annual shortage, with the 
recommended policy instead of the existing Min/Max policy, 
drugs in BE group with a type 1 demand character 
experienced a similar level of the shortage which was 752 
units. A much larger decease from 965 to 475 units was 
found in drugs in BE group with a type 2 demand character. 
Drugs in BE group with a type 4 demand character 
experienced a decrease in the shortage from 192 to 52 
units.  
For the inventory-to-sale ratio, an increase from 0.05 to 
0.06 was seen in drugs in BN group with a type 1 demand 
character. A larger increase, from 0.05 to 0.14, was in the 
BN group with a type 4 demand character.  
In terms of the application of the recommended policy to 
the drugs with low consumption value (group C), CV group 
drugs with a type 1 demand character had a five days of 
shortage which was similar to that of the existing Min/Max 
policy. Those in CV group with a type 2 demand character 
experienced a large decrease of 11 to 2 days of shortage; 
while those with a type 4 demand character faced 14 days of 
the shortage similar to that of the existing policy.   
Regarding number of the annual shortage, with the 
recommended policy instead of the existing Min/Max policy, 
drugs in CE group with a type 1 demand character 
experienced a decrease from 4,570 to 3,765 units; while 
those with a type 2 demand character had a dramatic 
decrease from 1,047 to 42 units. Decreases from 6,395 to 
5,626 units, and from 14 to 6 units were found in drugs in 
CE group with types 3 and 4 demand character, 
respectively.  
 In terms of the inventory-to-sale ratio, drugs in CN class 
with a type 1 demand character experienced a slight 
increase from 0.05 to 0.06. Meanwhile, increases from 0.05 
to 0.07 and 0.05 to 0.09 were found in those with types 2 
and 4 demand character, respectively.  
In could be concluded that the existing Min/Max policy 
was not suitable for most drugs, but for some with a specific 
demand character. The application of inventory management 
policies in the hospital should take the consumption value 
and clinical importance of individual drugs into account. 
These unique attributes of drug products made the supply 
chain of the healthcare products different from those in other 
industries. In addition, our findings could be properly 
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applicable to hospitals with high-volume and diverse drug 
items.   
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